Oncogene
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 9.1 | Q1 | 94.8% | 2.474 | Q1 | 96.7% |
| 2024 | 7.3 | Q1 | 92.1% | 2.489 | Q1 | 96.9% |
| 2023 | 6.9 | Q1 | 84.5% | 2.334 | Q1 | 96.6% |
| 2022 | 8.0 | Q1 | 84.4% | 2.311 | Q1 | 96.6% |
| 2021 | 8.8 | Q1 | 85.7% | 2.360 | Q1 | 96.9% |
| 2020 | — | — | 3.395 | Q1 | 98.2% | |
| 2019 | — | — | 3.232 | Q1 | 98.1% | |
| 2018 | — | — | 3.127 | Q1 | 97.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0950-9232
ISSN
1476-5594
country
GBcoverage
1987-2026